Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK-PD”

972 trials

Showing 20 of 972 results

Early research (Phase 1)Study completedNCT00481117
What this trial is testing

Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 37
Testing effectiveness (Phase 2)Study completedNCT05284617
What this trial is testing

Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF

Who this might be right for
Heart Failure With Preserved Ejection Fraction
Rivus Pharmaceuticals, Inc. 67
Early research (Phase 1)Study completedNCT05011097
What this trial is testing

A Phase I Clinical Trial of Y150 in the Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Wuhan YZY Biopharma Co., Ltd. 20
Early research (Phase 1)Study completedNCT00848510
What this trial is testing

EMD 525797 in Colorectal and Ovarian Cancer Patients With Liver Metastases

Who this might be right for
Colorectal and Ovarian Cancer Patients With Liver Metastases
Merck KGaA, Darmstadt, Germany 41
Testing effectiveness (Phase 2)Study completedNCT02217410
What this trial is testing

CCFZ533X2201 - PoC Study in de Novo Renal Transplantation

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 59
Early research (Phase 1)Study completedNCT01044537
What this trial is testing

A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Pfizer 50
Not applicableStudy completedNCT01602614
What this trial is testing

Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection

Who this might be right for
Cytomegalovirus Infections
University of Alabama at Birmingham 18
Early research (Phase 1)Study completedNCT02418793
What this trial is testing

A Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B

Who this might be right for
Hemophilia AHemophilia B
OPKO Health, Inc. 27
Post-approval studies (Phase 4)Study completedNCT02365272
What this trial is testing

Pharmacokinetic/Pharmacodynamic Evaluation Amikacin in Critically Ill Patients Admitted at the Emergency Department

Who this might be right for
Sepsis
Universitaire Ziekenhuizen KU Leuven 100
Very early researchStudy completedNCT01722669
What this trial is testing

Quercetin PK/PD Study in Healthy Adults and Patients With Hypercoagulable States

Who this might be right for
Healthy
Beth Israel Deaconess Medical Center 38
Early research (Phase 1)Study completedNCT01981694
What this trial is testing

A Phase I Trial to Investigate the Safety and Tolerability of PF-06649751

Who this might be right for
Healthy
Pfizer 18
Testing effectiveness (Phase 2)Study completedNCT02581657
What this trial is testing

Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM

Who this might be right for
Type 2 Diabetes Mellitus
PhaseBio Pharmaceuticals Inc. 37
Large-scale testing (Phase 3)Study completedNCT00488839
What this trial is testing

IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Impax Laboratories, LLC 173
Early research (Phase 1)Study completedNCT00958477
What this trial is testing

Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate Cancer

Who this might be right for
Prostate CancerBone Metastases
Merck KGaA, Darmstadt, Germany 26
Early research (Phase 1)Study completedNCT03655301
What this trial is testing

Effect of Copanlisib on Metformin Pharmacokinetics and Pharmacodynamics

Who this might be right for
Healthy Volunteers
Bayer 13
Early research (Phase 1)Study completedNCT00868595
What this trial is testing

MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer

Who this might be right for
Castrate Resistant Prostate Cancer (CRPC)
Bellicum Pharmaceuticals 18
Testing effectiveness (Phase 2)Study completedNCT05929339
What this trial is testing

Defining a PK and PD Model for Peripheral Analgesia After IV Oxytocin

Who this might be right for
Acute PainChronic PainHealthy Volunteer
Wake Forest University Health Sciences 25
Early research (Phase 1)Study completedNCT01316432
What this trial is testing

PK/PD Study of Subcutaneous Cenderitide Infusion in CHF Patients

Who this might be right for
Heart FailureADHFChronic Heart Failure+1 more
Nile Therapeutics 58
Early research (Phase 1)Study completedNCT03646721
What this trial is testing

Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DM

Who this might be right for
Diabetes Mellitus, Type 2
Dong-A ST Co., Ltd. 108
Testing effectiveness (Phase 2)Ended earlyNCT03568071
What this trial is testing

Assess Efficacy, Safety, Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Lakefront Biotherapeutics NV 207
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation